Sentinel Node Biopsy Market Size, Share & Trends Report

Sentinel Node Biopsy Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Surgical Instruments, Imaging Agents, Diagnostic Kits), By Application (Breast Cancer), By Procedure, By End Use (Hospitals & Clinics, Others), By Region And Segment Forecasts

Market Segmentation

Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Surgical Instruments:
  - Needles
  - Probes
  - Others
- Imaging Agents
  - Radioactive Tracers
  - Fluorescent Dyes
  - Contrast Agents
- Diagnostic Kits
  - Equipment
  - Reagents
Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Colon Cancer
- Esophageal Cancer
- Others
Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Open Surgery
- Minimally Invasive Surgery
Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Diagnostic Centers
Sentinel Node Biopsy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - North America Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - North America Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - North America Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - U.S.
    - U.S. Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - U.S. Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - U.S. Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - U.S. Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Canada
    - Canada Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Canada Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Canada Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Canada Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Europe
  - Europe Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Europe Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Europe Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Europe Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - UK
    - UK Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - UK Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - UK Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - UK Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Germany
    - Germany Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Germany Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Germany Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Germany Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Italy
    - Italy Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Italy Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Italy Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Italy Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - France
    - France Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - France Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - France Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - France Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Spain
    - Spain Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Spain Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Spain Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Spain Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Denmark
    - Denmark Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Denmark Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Denmark Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Denmark Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Sweden
    - Sweden Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Sweden Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Sweden Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Sweden Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Norway
    - Norway Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Norway Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Norway Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Norway Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Asia Pacific
  - Asia Pacific Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Asia Pacific Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Asia Pacific Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Asia Pacific Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - Japan
    - Japan Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Japan Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Japan Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Japan Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - China
    - China Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - China Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - China Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - China Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - India
    - India Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - India Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - India Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - India Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - South Korea
    - South Korea Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - South Korea Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - South Korea Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - South Korea Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Australia
    - Australia Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Australia Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Australia Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Australia Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Thailand
    - Thailand Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Thailand Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Thailand Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Thailand Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Latin America
  - Latin America Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Latin America Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Latin America Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Latin America Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - Brazil
    - Brazil Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Brazil Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Brazil Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Brazil Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Mexico
    - Mexico Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Mexico Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Mexico Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Mexico Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Argentina
    - Argentina Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Argentina Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Argentina Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Argentina Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- MEA
  - MEA Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - MEA Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - MEA Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - MEA Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - South Africa
    - South Africa Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - South Africa Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - South Africa Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - South Africa Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Saudi Arabia
    - Saudi Arabia Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Saudi Arabia Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Saudi Arabia Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Saudi Arabia Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - UAE
    - UAE Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - UAE Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - UAE Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - UAE Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Kuwait
    - Kuwait Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Kuwait Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Kuwait Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Kuwait Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments